This research study will test a new investigational continuous glucose monitoring system (System). The purpose of this study is to find out about the performance of the System in a home use environment over a 15 day period, in people with diabetes.
Study Type
OBSERVATIONAL
Enrollment
31
This is not an interventional study. Subjects must maintain their own diabetes treatment regimen throughout the study duration
Atlanta Diabetes Associates
Atlanta, Georgia, United States
Southwest Clinical Research Center
Santa Fe, New Mexico, United States
Clarke Error Grid Analysis
Percentage of CGM results in the clinically accurate Zone A and percentage of CGM results in the clinically acceptable Zones A and B of the Clarke Error Grid versus blood glucose reference.
Time frame: 15 days sensor wear
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.